Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    0.00 (0.00%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

30 Mar 2015 07:00

RNS Number : 7560I
Diploma PLC
30 March 2015
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

30 March 2015

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2015, ahead of going into its close period.

 

Trading Summary

The businesses acquired during the past year have made a good contribution to the Group's overall results and revenues for the six months ending 31 March 2015 are expected to be ca. 9% ahead of the comparable period. The acquired businesses have contributed ca. 9% to Group revenues, but currency volatility has continued to impact the Group's results, reducing revenues by ca. 2%. On an underlying basis, after adjusting for the impact of currencies and acquisitions, revenues are expected to increase by ca. 2%.

 

The main driver to revenue growth has been from the Seals businesses where revenues have benefited both from acquisitions completed last year and from strong demand, particularly in the North American Seals businesses. In Life Sciences, the recent acquisition of the TPD business has contributed to a strong increase in headline revenues. Underlying growth has been flat as the Canadian Healthcare businesses have faced tougher markets, with hospitals increasing their focus on controlling costs as they approach the end of their budgetary fiscal year. In Controls, underlying revenues have reduced against the strong prior year comparative, reflecting lower activity in the Motorsport and Aerospace fastener sectors and softer European industrial markets.

 

Currency movements have continued to impact the Group's results on both a translational and transactional basis. Further depreciation against UK sterling, relative to last year, of the Euro and the Canadian and Australian dollars, more than offset the impact from the appreciation of the US dollar. The transactional impact from currency depreciation on the Life Sciences businesses has contributed to a slightly lower Group operating margin, as anticipated.

 

Financial Position

After spending ca. £34m on completing the acquisitions of TPD (Life Sciences) in October 2014 and Kubo (Seals) in early March 2015, the Group expects to have net debt of ca. £18m at 31 March 2015, compared with cash balances of £21.3m at 30 September 2014.

 

The Board will provide a further update on trading prospects for the year when the Group's Half Year's results are announced on Monday, 11 May 2015.

 

 

 

 

Note: A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,300 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of 20% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £900m.

 

 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUWGWUPAGQM
Date   Source Headline
14th Feb 202510:34 amRNSHolding(s) in Company
17th Jan 20259:34 amRNSDirector/PDMR Shareholding
15th Jan 20252:56 pmRNSResult of AGM
15th Jan 202510:19 amRNSAppointment of Non-Executive Director
15th Jan 20257:00 amRNS1st Quarter Results
10th Jan 20258:56 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20244:25 pmRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSBoard Committee Changes
27th Nov 20247:00 amRNSDirector/PDMR Grant of LTIP Awards
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
15th Nov 20247:00 amRNSIssue of Shares & Total Voting Rights
8th Oct 20247:00 amRNSAppointment of Non-Executive Director
13th Sep 20247:00 amRNSAppointment of Senior Independent Director
29th Jul 20242:25 pmRNSDirector Declaration
18th Jul 20247:00 amRNSQ3 Trading Statement
16th Jul 20247:00 amRNSBoard Changes
4th Jun 202411:18 amRNSHolding(s) in Company
13th May 20247:00 amRNSHalf Year Results
2nd May 20247:00 amRNSAcquisition
25th Apr 20243:54 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSAcquisition
5th Mar 20242:07 pmRNSHolding(s) in Company
17th Jan 20243:21 pmRNSResult of AGM
17th Jan 20247:00 amRNSQ1 trading update
20th Dec 20237:00 amRNSAppointment of Non-Executive Director
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202311:31 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSAnnual Financial Report & Notice of AGM
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSDirector/PDMR Grant of LTIP Awards
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSFull Year Results
16th Nov 20237:00 amRNSIssue of Shares & Total Voting Rights
10th Oct 202312:29 pmRNSHolding(s) in Company
21st Aug 202310:10 amRNSHolding(s) in Company
15th Aug 20233:54 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSStrategic acquisition in European Fluid Power
13th Jul 20237:00 amRNSQ3 Trading Update
27th Jun 20237:00 amRNSCapital Markets Seminar
13th Jun 20235:09 pmRNSHolding(s) in Company
7th Jun 20233:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.